Advertisement

Research Article Free access | 10.1172/JCI110357

A model of decreased functional alpha-1-proteinase inhibitor. Pulmonary pathology of dogs exposed to chloramine T.

W R Abrams, A B Cohen, V V Damiano, A Eliraz, P Kimbel, D R Meranze, and G Weinbaum

Find articles by Abrams, W. in: PubMed | Google Scholar

Find articles by Cohen, A. in: PubMed | Google Scholar

Find articles by Damiano, V. in: PubMed | Google Scholar

Find articles by Eliraz, A. in: PubMed | Google Scholar

Find articles by Kimbel, P. in: PubMed | Google Scholar

Find articles by Meranze, D. in: PubMed | Google Scholar

Find articles by Weinbaum, G. in: PubMed | Google Scholar

Published November 1, 1981 - More info

Published in Volume 68, Issue 5 on November 1, 1981
J Clin Invest. 1981;68(5):1132–1139. https://doi.org/10.1172/JCI110357.
© 1981 The American Society for Clinical Investigation
Published November 1, 1981 - Version history
View PDF
Abstract

The objective of this study was to develop an animal model representative of chronic human alpha-1-proteinase inhibitor deficiency. Eight dogs were treated with a mild oxidizing agent, chloramine T, with varying regimens for 3--27 wk. The capacity of the serum to inhibit both trypsin and elastase was examined and found to respond differently. Although immunologically determined levels of protease inhibitor did not change, the ability of serum to inhibit elastase in an in vitro assay decreased in direct response to chloramine T treatment. The trypsin inhibitory capacity was less affected. Emphysemalike alterations in lung morphology were observable when histologic sections were evaluated both subjectively and objectively by mean linear intercept measurements. The data suggest that this model parallels the emphysema associated with the genetic alpha-1-proteinase inhibitor deficiency in man.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (November 1, 1981): No description
Advertisement
Advertisement